Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
Reumatologia Clinica|February 10, 2012
[Biopathology of the synovial membrane in psoriatic arthritis]Juan D CañeteClinical and Experimental Rheumatology|August 4, 2019
Good clinimetric alignment between remission and a low impact of disease in patients with axial psoriatic arthritisRubén Queiro, Juan D CañeteExpert Opinion on Drug Safety|June 9, 2018
Anakinra for the treatment of rheumatoid arthritis: a safety evaluationJulio Ramírez, Juan D CañeteClinical Rheumatology|January 31, 2018
Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?Rubén Queiro, Juan D CañeteCurrent Topics in Medicinal Chemistry|April 12, 2013
Immunopathology of rheumatoid arthritisJosé L Pablos, Juan D CañeteCurrent Topics in Medicinal Chemistry|April 12, 2013
Biologic therapy in rheumatoid arthritisJuan D Cañete, José L PablosMethods in Molecular Biology (Clifton, N.J.)|May 3, 2014
Determination of soluble tumor necrosis factor receptor 2 produced by alternative splicingXavier Romero, Juan D Cañete, Pablo EngelBest Practice & Research. Clinical Rheumatology|September 30, 2004
Palindromic rheumatism and other relapsing arthritisRaimon Sanmarti, Juan D Cañete, Georgina SalvadorExpert Review of Clinical Immunology|March 5, 2021
Palindromic rheumatism: a unique and enigmatic entity with a complex relationship with rheumatoid arthritisRaimon Sanmartí, Isabel Haro, Juan D CañeteExpert Opinion on Drug Safety|March 2, 2016
The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritisMaria Victoria Hernández, Raimon Sanmartí, Juan D CañetePageof 19